BioMarine Business Convention

The BioMarine Business Convention takes place in Halifax, Canada September 9-12, 2013. The programme will have three themes: Marine Natural Products, Aquaculture and Aquafeed, and Marine Bio-Technologies. The programme will comprise of a series of interactive sessions, multiple networking opportunities, and key notes from international senior executives, top experts and dignitaries.

More information...

English: Canadian Horseshoe Falls with city of Buffalo, US in background. Clicked from Skylon Tower, Niagara Falls, Canada. (Photo credit: Wikipedia)

BioMarine Business Convention 2013 preliminary programme

With 2012 done and dusted, attention now turns to the next BioMarine Business Convention in Halifax, Canada. Scheduled for September 9-12, 3012, the 2013 programme will comprise of a series of interactive sessions and think-tank, series of key notes from senior executives, top experts and celebrities.

If you wish to keep up with the latest developments in the biomarine industry then the interactive sessions are for you. If you prefer to take an active part in the future recommendations and contribute to the final reports, you will choose to participate to the think-tanks. If you wish to invest or scout the best innovative technology and projects then the Innovation Forum is the place you will attend. Plan, organise and meet: BioMarine one-to-one business meetings will also offer you a world of business opportunities.

More information...

Halifax (Photo credit: joshbousel)

BioMarine in International Aquafeed magazine

The BioMarine Business Convention 2012 features in the new issue of International Aquafeed magazine.

The event is shown into the spotlight with a 16-page supplement including proceedings from the six Think Tanks and debates.

Read the full report online here or the view the whole issue online here.

International Aquafeed January/February 2013

BioMarine Business Convention supplement in International Aquafeed magazine

Happy new year everyone.  I hope you all had a great 2012 and 2013 is off to a flying start.

I wanted to let you know that the next issue of International Aquafeed magazine will feature a 12-page BioMarine supplement on the highlights and outcomes of the BioMarine Business Convention held in London in October 2012. It is really exciting working on such a big project and I am looking forward to sharing the results with you.

Don't forget, registration is open for the next BioMarine Business Convention, which will take place in Halifax, Canada, September 9-12, 2013. More information...

Event: Invitation to attend the 4th BioMarine Business Convention

Halifax, Canada welcomes the 4th BioMarine Business Convention from September 9 - 12, 2013. This unique four-day international business convention is co-organised by BioTopics SAS and the National ResearchCouncil of Canada (NRC). 

Dedicated to marine bio resources, marine ingredients, aquafeed and aquaculture, macro and micro algae, nutraceuticals, cosmetics, marine biotechnology for health and environment, bio materials, biofuels, renewable marine energies (tidal and offshore wind), green shipping, ports and environmentals, spatial planning, law of the sea.

The BioMarine Business Convention brings together international participants from business, science and civil society communities to discover and share innovative solutions for advancing sustainable ocean development.

More information...

BioMarine profile: Pronova BioPharma

Pronova is a global leader in research, development and manufacture of lipid therapies derived from nature.

The group's first commercialised product, Omacor/Lovaza, is branded in a number of countries (57) throughout Europe, Asia and in the USA. End-user sales has grown rapidly in all international  markets and the annual run rate at 31 December 2011 reached USD 1 380 million, according to IMS Health. The product is the first EU- and FDA-approved omega 3-derived prescription drug.

Marketing and distribution of Pronova's key product is currently licensed to both local and global pharmaceutical companies.

The company is in the process of developing several new, patentable lipid derivatives. The most advanced lipid derived pharmaceutical programme is in the area of combined dyslipidemia, the abnormal concentration of lipids and lipoproteins in the blood, for which the company has a product, PRC-4016, in clinical trials.

Pronova has also announced plans to enter the consumer health care and clinical nutrition markets, enabling the company to further leverage its position as the world's largest manufacturer of high grade omega-3 derived products.

Pronova's headquarters are located at Lysaker in Norway, while production takes place at state of-the-art manufacturing facilities at Sandefjord in Norway and in Kalundborg, Denmark. The company's shares are listed on Oslo Børs with the ticker code PRON.

Additional information is available here.